ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
AN2 Therapeutics Inc

AN2 Therapeutics Inc (ANTX)

2.35
-0.07
(-2.89%)
Closed May 13 4:00PM
2.53
0.18
( 7.66% )
Pre Market: 6:51AM

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -7.68M-10.33M-11.77M-12.48M-16.04M-16.6M-18.18M-18.82M
Pre Tax Income -7.66M-10.12M-11.34M-11.84M-15.32M-15.8M-16.71M-16.9M
Net Income -9.48M-10.12M-11.34M-11.84M-15.32M-15.8M-16.71M-16.9M
Preferred Dividends -1.82M0000000
Basic Earnings Per Share (EPS) 00000000
EBIT -7.68M-10.35M-11.81M-12.47M-15.32M-15.8M-16.71M-16.9M
EBITDA -7.68M-10.33M-11.77M-12.48M-16.04M-16.6M-18.18M-18.82M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Revenue 000
Operating Income -21.61M-42.26M-69.64M
Pre Tax Income -21.54M-40.96M-64.73M
Net Income -28.06M-42.78M-64.73M
Preferred Dividends -6.52M-1.82M0
Basic Earnings Per Share (EPS) -0.005-2.205-2.177
EBIT -21.61M-42.31M-64.73M
EBITDA -21.61M-42.26M-69.64M

Your Recent History

Delayed Upgrade Clock